Skip Navigation
Skip to contents

SICEM2025

Thyroid

Thyroid

Clinical update 1. Global guideline review in thyroid diseases Day 2, Friday, April 12, 08:30-10:00 / Room 2 (1F) Overview
Given the increasing global prevalence of thyroid disorders, session has been organized to explore the latest clinical guidelines. In this session, Prof. Susan Mandel, Prof. Eun Kyung Lee, and Prof. Eu Jeong Ku will present lectures on key aspects of the most recent guidelines from the American Thyroid Association and the Korean Thyroid Association. This aim of this session is to provide healthcare professionals with an overview of the current trends in thyroid disorders and offer practical knowledge applicable to clinical settings.

Chairpersons : Won Bae Kim (University of Ulsan, Korea), Ho-Cheol Kang (Chonnam National University, Korea)

08:30-09:00 Highlights from the 2024 ATA guidelines on the management of thyroid nodules Susan Mandel (University of Pennsylvania, USA)
09:00-09:30 Changing perspectives in the KTA guideline for thyroid cancer Eun Kyung Lee (National Cancer Center, Korea)
09:30-10:00 Recent update in guidelines for subclinical hypothyroidism Eu Jeong Ku (Seoul National University, Korea)
Symposium 8. Thyroid and metabolic disease Day 3, Saturday, April 13, 08:30-10:00 / Room 2 (1F) Overview
This session aligns with the theme of SICEM 2024, ‘One Endo.' It features three lectures on thyroid hormone disorders and metabolic diseases. Prof. Rohit A. Sinha will discuss the relationship between thyroid hormones and non-alcoholic fatty liver disease. Prof. Hyon-Seung Yi will introduce the role of IL-17A-producing γδ T cells in metabolic complications of thyrotoxicosis. Lastly, Prof. Yong-Ho Lee will cover the association between thyroid function and metabolic parameters.

Chairpersons : Do Joon Park (Seoul National University, Korea), Minho Shong (KAIST, Korea)

08:30-09:00 Thyroid hormone and NAFLD Rohit A. Sinha (Sanjay Gandhi Post Graduate Institute of Medical Sciences, India)
09:00-09:30 IL-17A-producing γδ T cells govern metabolic complications of thyrotoxicosis Hyon-Seung Yi (Chungnam National University, Korea)
09:30-10:00 Thyroid hormones in diabetes and aging Yong-Ho Lee (Yonsei University, Korea)
Hot topic. Recent therapeutic trends of Graves' disease Day 3, Saturday, April 13, 11:20-12:50 / Room 2 (1F) Overview
In this session, we invited distinguished researchers to share their cutting-edge insights into the treatment of Graves' disease. Prof. Ken Okamura will deliver a lecture on the long-term prognosis of Graves' disease and explore the effectiveness and safety of prolonged anti-thyroid drug therapy. Prof. Jae Hoon Moon will introduce the incorporation of recent trends in artificial intelligence and wearable technology into the treatment of Graves' disease. Finally, Prof. Jin Sook Yoon will present the recent advancements in the treatment of thyroid eye disease, including newly developed drugs such as IGF-1 receptor antagonists.

Chairpersons : Sun Wook Kim (Sungkyunkwan University, Korea), Eun Kyung Lee (National Cancer Center, Korea)

11:20-11:50 Long term anti-thyroid drug therapy Ken Okamura (Kyushu university, Japan)
11:50-12:20 Revolutionizing management of Graves' disease: integrating new technologies for optimal patient care Jae Hoon Moon (Seoul National University, Korea)
12:20-12:50 Current and emerging therapies for thyroid eye disease Jin Sook Yoon (Yonsei University, Korea)
Korean Endocrine Society
101-2503, Lotte Castle President, 109, Mapo-daero, Mapo-gu, Seoul 04146, Republic of Korea
T. +82-2-714-2428  |  E. endo@endocrinology.or.kr  |  W. www.endocrinology.or.kr
Business Registration Number: 106-82-31133  |  Name of Representative : Yoon-Sok (Martin) Chung
SICEM 2025 Secretariat (INTO-ON)
4F, A-Block, Richensia, 341, Baekbeom-ro, Yongsan-gu, Seoul 04315, Republic of Korea
T. +82-2-2039-7804  |  E. info@sicem2025.kr  |   W. www.into-on.com

Copyright ⓒ The Korean Endocrine Society. All rights Reserved